))
Russia's Sputnik COVID19 Vaccine Trial - Efficacy and Limitations #9
ซีรีส์ที่ถูกเก็บถาวร ("ฟีดที่ไม่ได้ใช้งาน" status)
When?
This feed was archived on July 01, 2022 01:50 (
Why? ฟีดที่ไม่ได้ใช้งาน status. เซิร์ฟเวอร์ของเราไม่สามารถดึงฟีดพอดคาสท์ที่ใช้งานได้สักระยะหนึ่ง
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 285710716 series 2820537
เนื้อหาจัดทำโดย Kim Kristiansen and JG Staal เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก Kim Kristiansen and JG Staal หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal
Russia's Sputnik COVID19 Vaccine Trial - Efficacy and Limitations
- The Russian Sputnik COVID19 vaccine interim analysis has been published in the prestigious medical journal The Lancet
- Efficacy is comparable to vaccines like the Pfizer/BioNTech and Moderna vaccines
- But there are some serious concerns with the study and the published data reducing the usefulness of this vaccine and to whom it can be used
- You don’t want to miss this episode
GET THE ABSTRACT SCREENING TOOL
It can be a challenge to screen papers for clinical relevance. As we go beyond the abstract in this podcast, we have created a screening tool you can use when reading an abstract from a clinical research paper.
Using that tool enables you to quickly screen an abstract from a medical journal for clinical relevance selecting only those you want to read. At the same time, you will know why you skipped the rest. Get it at our website https://www.precision-evidence.com
LINKS:
The Sputnik COVID19 Vaccine trial in the Lancet https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00234-8/fulltext
Precision Evidence #8: “Critical Appraisal of the Moderna COVID19 Vaccine Trial”
https://www.precision-evidence.com/8
Precision Evidence #6: “Covid-19 Vaccines Trials: Understanding the First Published Results”
https://www.precision-evidence.com/6
Precision Evidence #5: “Covid-19 Vaccines Trials and Press Releases – Looking Beyond the Efficacy”
https://www.precision-evidence.com/5
NOTES:
- The interim analysis of the Russian Sputnik COVID19 vaccine is published in The Lancet
- It demonstrates efficacy at 94.6% which is comparable to the Pfizer/BioNTech and Moderna vaccine interim analysis
- Safety is comparable as well
- There are, however, when scrutinizing the study, some serious concerns with impact on the usefulness of the vaccine and reducing the precision of the evidence
Contact us at email: podcast@precision-evidence.com,
Twitter @PrecisionEBM,
You can learn more at our website, where you can also leave us a voice message
Website: www.precision-evidence.com
Hosts:
Dr. Kim Kristiansen, M.D: @KKristiansenMD
JG Staal: @HealthyEvidence
Music thanks to mixkit.co
13 ตอน
แบ่งปัน
